Additional Information
Book Details
Abstract
Even though it seems simple the ability of the mother’s body to retain and nurture the fetus, which is of a non-identical genetic makeup, throughout the gestational period requires a delicate balance of hormonal orchestration to achieve the required immunological permissiveness. The obvious outcome of a failure to achieve this is rejection of the fetal "semi-allograft", which manifests as threatened miscarriage.
The occurrence of threatened miscarriage or symptoms suggestive of it is fraught with anxiety both for the patient and the obstetrician, especially if the baby is eagerly awaited. In such a situation, a correct diagnosis and prompt evaluation is imperative to start immediate interventions and prevent the expulsion of the fetus. However it is equally important to rule out the other conditions that may mimic threatened miscarriage and avoid unnecessary interventions.
This clinical update handbook attempts to address these and other issues associated with this potentially elusive condition. The first chapter serves to give a concise yet relevant overview about this topic. The various modes of presentation as well as the management protocol are elaborately covered in the second chapter. The chapter on Diagnostic Modalities explains how the risk factors and investigative findings can be used to predict and make an early diagnosis of the condition. It has also touched upon the other conditions that mimic threatened miscarriage and how those can be differentiated from it. The role of stress and how it affects the immunomodulation which is the basis of maternal tolerance of the fetus, is explored in detail in the fourth chapter. The last chapter highlights the complications associated with inappropriate treatment of the condition and explores the adverse effects and relative safety of the recommended treatment protocol. Most of the chapters also include several case reviews that illustrate the aspects covered and are enriched with the vast repertoire of personal experience of the eminent authors.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover\r | Front Cover | ||
Front Matter \r | ia | ||
Copyright | id | ||
ECAB Clinical Update:Obstetrics & Gynecology | ie | ||
Threatened Miscarriage | if | ||
About the Authors | ig | ||
Contents | ik | ||
ECAB Clinical Update InformationThreatened Miscarriage | i | ||
Threatened Miscarriage-An Overview | 1a | ||
ABSTRACT | 1a | ||
KEYWORDS | 1b | ||
Definition and Associated Terminology | 1a | ||
Prevalence | 2 | ||
Causes of Threatened Miscarriage | 2 | ||
Presenting Features | 3 | ||
Early Diagnosis and Prediction of Outcome of Threatened Miscarriage | 3 | ||
Maternal Risk Factors | 4 | ||
Period of Gestation and Type of Bleeding | 5 | ||
Biochemical Markers | 5 | ||
Ultrasonographic Indicators | 7 | ||
Prediction of Miscarriage | 8 | ||
Management of Threatened Miscarriage | 8 | ||
Bed Rest | 9 | ||
Progesterone | 9 | ||
Dydrogesterone | 10 | ||
Human Chorionic Gonadotropin | 11 | ||
Uterine Muscle Relaxants | 11 | ||
Long-Term Gestational Outcome | 11 | ||
Conclusion | 12 | ||
Clinical Presentation and Management of Emergent and Non-Emergent Status | 17a | ||
ABSTRACT | 17a | ||
KEYWORDS | 17b | ||
Abortion or Miscarriage: Choice of Term | 17 | ||
Incidence of Miscarriage | 18 | ||
Impact on Fetal and Maternal Health | 19 | ||
Clinical Presentation | 19 | ||
Emergent Threatened Miscarriage | 20 | ||
Non-Emergent Threatened Miscarriage | 21 | ||
Evaluation of the Case with Bleeding Per Vaginum | 22 | ||
History | 23 | ||
Clinical Examination | 23 | ||
Role of Ultrasonography in Evaluation | 24 | ||
Laboratory Investigations | 29 | ||
Treatment | 31 | ||
Supportive Management | 31 | ||
Progesterone Supplementation | 33 | ||
Natural/Micronized Progesterone | 34 | ||
Dydrogesterone | 34 | ||
17-Alphahydroxyprogesterone Caproate | 34 | ||
Cause-specific Treatment | 35 | ||
Subsequent Follow-up | 38 | ||
Assisted Reproductive Technology and Miscarriages | 38 | ||
Conclusion | 39 | ||
Acknowledgements | 40 | ||
Case Studies Clinical Presentation and Management of Emergent and Non-Emergent Status | 45 | ||
Case 1 | 45 | ||
Case 2 | 47 | ||
Case 3 | 48 | ||
Case 4 | 49 | ||
Case 5 | 50 | ||
Case 6 | 52 | ||
Diagnostic Modalities: Prediction and Early Detection of Threatened Miscarriage | 54a | ||
ABSTRACT | 54a | ||
KEYWORDS: | 54b | ||
Introduction | 54a | ||
Incidence | 55 | ||
Diagnostic Approach | 55 | ||
Ruling Out Other Causes with Similar Symptoms | 55 | ||
Normal Intrauterine Pregnancy | 56 | ||
Inevitable Miscarriage | 56 | ||
Incomplete Miscarriage | 56 | ||
Delayed Miscarriage (Earlier called Missed Abortion) | 56 | ||
Ectopic Pregnancy | 58 | ||
Gestational Trophoblastic Disease | 59 | ||
Assessment of Viability and Prediction of Outcome of Pregnancy: Role of Clinical Evaluation | 59 | ||
Diagnostic Modalities to Assess Viability and Predict Outcome of Pregnancy | 61 | ||
Sonological Markers | 61 | ||
Biochemical Markers | 65 | ||
Risk Factors to Predict Threatened Miscarriage | 72 | ||
Higher Maternal Age | 72 | ||
Stress | 73 | ||
Low Body Mass Index | 73 | ||
Conclusion | 75 | ||
Case Studies Diagnostic Modalities: Prediction and Early Detection of Threatened Miscarriage | 81 | ||
Case Summaries | 81 | ||
Case 1 | 81 | ||
Case 2 | 82 | ||
Stress and Immunomodulation in Threatened Miscarriage | 83a | ||
ABSTRACT | 83a | ||
KEYWORDS | 83a | ||
Introduction | 83a | ||
Implantation of the Conceptus | 85 | ||
Impact of Stress on Conception, Implantation and Continuation of Pregnancy | 88 | ||
Pathophysiology of Stress-Induced Injury8 | 90 | ||
Role of Cytokines in Pregnancy | 92 | ||
Role of Corticotropin-releasing Hormone (CRH) in Pregnancy | 94 | ||
Role of Progesterone | 96 | ||
Personal Experience in Patients with Recurrent Pregnancy Loss | 97 | ||
Overview of Management of Stress-Induced Threatened Miscarriages | 99 | ||
Conclusion | 100 | ||
Case Study Stress and Immunomodulation in Threatened Miscarriage | 102 | ||
Case | 102 | ||
Complications of Threatened Miscarriage and Follow-up Care | 103 | ||
Introduction | 103 | ||
Progesterone Supplementation in Threatened Miscarriage | 104 | ||
Benefits of Progesterone Administration | 105 | ||
Adverse Effects of Inappropriate Administration | 106 | ||
Role of hCG Supplementation: Useful or Necessary? | 108 | ||
Role of Estrogen: Lessons from the Past | 108 | ||
Cervical Encirclage | 109 | ||
Role of Cervical Encirclage: Is it Needed in All Cases? | 109 | ||
Personal Experience | 112 | ||
Pregnancy Outcome with Threatened Miscarriage | 112 | ||
Serious Consequences Like Disseminated Intravascular Coagulation (DIC) and Death Associated with Threatened Miscarriage | 116 | ||
Follow-Up Care | 117 | ||
Personal Experience | 118 | ||
Conclusion | 119 | ||
ECAB Clinical Update: Obstetrics & Gynecology-Other Books in This Series | 124 | ||
Polycystic Ovary Syndrome | 124 | ||
Menopause | 125 | ||
Fertility Control | 125 | ||
Perinatal Medicine | 126 | ||
Obstetrics Counseling | 126 | ||
Medical Disorders in Pregnancy | 127 | ||
Recurrent Pregnancy Loss | 128 | ||
Endoscopy in Infertility (Part I): A Perspective on Hysteroscopy | 128 | ||
Endoscopy in Infertility (Part II): A Perspective on Laparoscopy | 129 | ||
Gynecologic Endocrinology | 130 | ||
High-Risk Labor and Delivery | 130 | ||
Assisted Reproductive Technology | 131 | ||
Endometriosis | 132 | ||
Amenorrhea | 133 |